Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Neuromodulation. 2022 Jun 14;25(6):846–853. doi: 10.1111/ner.13504

Figure 2. Impact of the BDNF rs6265 SNP on UPDRS parts I-IV over 2 years.

Figure 2.

T allele carriers in the MT arm displayed significantly higher (worse) UPDRS-II scores at 24 months compared to C/C subjects (B, *, p = 0.017). In the other UPDRS parts, no significant differences were observed due to either rs6265 genotype or treatment (A, C-H, p > 0.05). Values represent the mean ± SEM.